Moreover, they demonstrated that the simultaneous activation of p53 and inhibition of c-Myc decrease viability and induce apoptosis of CML LSCs without measurable effects on normal HSCs [41]. This evidence concerns the gene MYC and chronic myelogenous leukemia, BCR-ABL1 positive.